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Hepatitis delta virus (HDV) encodes a single protein, the hepatitis delta antigen (HDAg), which is thought to be translated
from a 0.8-kb RNA of antigenomic sense. This subgenomic RNA species is present in very small amounts in HDV-infected
liver tissues and in cultured cells infected or transfected with HDV, and in some cases it cannot be detected at all. In contrast,
HDAg protein is present in large amounts in all natural and experimental models of HDV infection. This study addresses
whether other HDV RNA species, such as the antigenomic-sense, genome-size HDV RNA can also serve as the mRNA for
HDAg synthesis. Taking advantage of the ability of herpes simplex virus (HSV) to degrade only polyadenylated mRNAs, we
examined the effect of HSV coinfection on HDAg synthesis. It was shown that HSV infection did degrade the subgenomic
0.8-kb HDV mRNA but not HDV genome-length RNA. Under such conditions, HDAg synthesis was completely inhibited.
Furthermore, the genome-length HDV RNA was found not to be associated with polysomes. Finally, in vitro translation studies
demonstrated that HDAg could not be translated directly from the genome-length antigenomic-sense HDV RNA. These
results suggest that only the subgenomic RNA species of HDV possesses properties characteristic of the mRNA for HDAg
and that the genome-length RNA cannot be used for translating HDAg. In addition, we found that HDV RNA replication did
not depend on de novo HDAg synthesis. © 1998 Academic Press
INTRODUCTION
Hepatitis delta virus (HDV) is a subviral satellite virus
of hepatitis B virus that is often associated with fulminant
hepatitis (Polish et al., 1993; Rizzetto, 1983). It has a
single-stranded circular RNA genome of ;1700 nucleo-
tides, which folds intramolecularly to form an un-
branched rod-like structure with ;70% bases paired
(Wang et al., 1986). The virus undergoes RNA-dependent
RNA replication via a double-rolling circle mechanism,
which is likely mediated by cellular RNA polymerase II
and cellular transcription factors (Lai, 1995). These fea-
tures are reminiscent of the plant subviral RNA patho-
gens known as viroids (Diener, 1979; Symons, 1990).
However, unlike viroids, HDV encodes a viral protein, the
hepatitis delta antigen (HDAg).
HDAg is the only known protein encoded by HDV, and
it constitutes the viral nucleocapsid. It is a nuclear phos-
phoprotein in infected liver cells (Chang et al., 1988) and
binds to HDV RNA (Lee et al., 1993). In addition to its
structural role as a component of the HDV nucleocapsid,
it plays a major role in the life cycle of HDV. HDAg exists
as two distinct species: a 27-kDa (214 amino acids) large
HDAg (LHDAg) and a 24-kDa (195 amino acids) small
HDAg (SHDAg). The two protein species are identical in
sequence except at the C terminus, where LHDAg con-
tains an additional 19 amino acids. SHDAg is required for
HDV RNA replication in a trans-acting function (Kuo et al.,
1989), whereas LHDAg inhibits replication (Chao et al.,
1990) and is required for virus assembly (Chang et al.,
1991).
HDAg is thought to be translated from an 800-nucleotide,
polyadenylated RNA of antigenomic sense, detected in the
cytoplasm of HDV-infected or -transfected cells (Hsieh et
al., 1990). This subgenomic RNA species is transcribed
from near one end of the rod-like RNA structure and termi-
nates at a polyadenylation signal (Hsieh et al., 1990; Mo-
dahl and Lai, 1998). It is usually present in very small
amounts (;500–6000 times less than the genome-length
genomic-sense RNA) in HDV-infected liver tissue (Chen et
al., 1986) and in cultured cells infected or transfected with
HDV (Hsieh et al., 1990). Furthermore, in many cell lines or
infected tissues, this RNA could not be detected at all; for
example, in transgenic mice in which HDV RNA undergoes
active replication, no 0.8-kb mRNA was detected (Polo et
al., 1995a). It was thought that the synthesis of this sub-
genomic mRNA represents the initial step of RNA replica-
tion and that its synthesis is inhibited by HDAg, thus ex-
plaining the paucity of this mRNA species in most HDV-
replicating cells (Hsieh and Taylor, 1991; Hsieh et al., 1994).
However, our recent study showed that this was not the
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case and that this subgenomic mRNA could be detected in
large amounts using an HDV RNA transfection approach
(Modahl and Lai, 1998). Furthermore, in HDV cDNA trans-
fection experiments, HDAg synthesis could occur in the
absence of RNA replication and autocleavage activity, sug-
gesting that subgenomic mRNA synthesis is not linked to
HDV RNA replication (MacNaughton et al., 1993). Neverthe-
less, the low abundance or absence of this subgenomic
mRNA species in most HDV-replicating cells contrasts with
the abundance of HDAg protein in all natural and experi-
mental models of HDV infection. One possible explanation
is that other HDV RNA species, such as genome-length
antigenomic-sense HDV RNA, may also serve as the mRNA
for HDAg synthesis (Lai, 1995).
To examine the possible RNA species used for the
translation of HDAg, several approaches were under-
taken in the current study. The first involved the infection
of HDV-replicating cells with herpes simplex virus (HSV).
Cells infected with HSV undergo a rapid shutoff of host
protein, RNA, and DNA synthesis (Fenwick and Walker,
1978; Nishioka and Silverstein, 1977; Roizman et al.,
1965). The shutoff of protein synthesis has been traced to
the action of the HSV-encoded virion host shutoff (vhs)
protein (Kwong et al., 1988; Read and Frenkel, 1983). The
vhs is capable of inducing or accelerating the degrada-
tion of polyadenylated mRNA species in the cytoplasm
(Fenwick and McMenamin, 1983; Nakai et al., 1982;
Schek and Bachenheimer, 1985; Strom and Frenkel,
1987; Zelus et al., 1996) while leaving rRNA and tRNA
unaffected (Oroskar and Read, 1989). Efficient shutoff of
host protein synthesis is not observed with virions con-
taining a mutant vhs polypeptide (Lam et al., 1996; Strom
and Frenkel, 1987). The rationale for this approach is as
follows. Because the 0.8-kb mRNA is polyadenylated, it
will presumably be degraded after HSV infection. If other
unconventional RNA species also serve as a template for
HDAg synthesis, then HDAg synthesis will not be com-
pletely inhibited by HSV infection. The second approach
determined whether the HDV genome-length RNA or
other RNA species are associated with polysomes and
thus are being translated. In both of these studies, we
found that only the subgenomic RNA species of HDV
behaved as a characteristic mRNA for HDAg. Further-
more, in vitro translation experiments showed that HDAg
could not be translated from the genome-length anti-
genomic-sense HDV RNA in an internal ribosomal entry
site (IRES)-dependent manner, thus ruling out the ge-
nome-length HDV RNA as a direct template for HDAg
synthesis.
RESULTS
Accumulation of mRNA for HDAg is diminished after
HSV-1 infection
To establish that HSV-1 infection could be used as a
tool to characterize the template for HDAg synthesis, a
preliminary experiment was performed to determine
whether the mRNA containing an open reading frame
(ORF) for HDAg was degraded after HSV-1 infection.
TSd3 cells, which constitutively express an SHDAg-en-
coding mRNA from an integrated cDNA (Hwang et al.,
1995), were infected with HSV-1, and total cellular RNA
was harvested at various time points p.i. for the exami-
nation of various RNA species. HSV-induced cytopathic
effects (CPE) were observed beginning at 4 h and were
markedly present at 8 h p.i.
Figure 1 shows that both the mRNAs for a cellular
protein, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and HDAg started to decline before 9 h p.i. and
were completely undetectable by 25 h p.i. This result
indicated that the mRNA for HDAg behaved like other
cellular mRNAs and was degraded after HSV-1 infection,
although we could not rule out the possibility that HSV-1
infection may inhibit HDAg mRNA transcription as well.
Nevertheless, this result indicates that the HDAg mRNA
became undetectable after HSV-1 infection. There was
an increase in both GAPDH and HDAg mRNAs at 5 h p.i.,
but this observation was not reproducible. In contrast to
GAPDH and HDAg mRNAs, the level of 28S rRNA did not
vary throughout the experiment, which is consistent with
the previous reports that only mRNAs, not rRNAs or
tRNAs, are degraded after HSV-1 infection (Oroskar and
Read, 1989).
Effects of HSV-1 infection on HDV RNA species in
various HDV RNA-replicating cell lines
To examine the potential role of the different HDV RNA
species as templates for HDAg synthesis, the effects of
FIG. 1. Effects of HSV-1 infection on HDAg mRNA. TSd3 cells were
either mock-infected (lane 1) or infected with HSV-1 (lanes 2–4), as
indicated at the top. RNA was harvested at the indicated time points p.i.
and examined by Northern blotting. The probes used were genomic-
sense monomer HDV RNA [to detect antigenomic-sense (aG) HDV
RNA], GAPDH, and 28S rRNA. (Bold arrow) HDAg mRNA species. (Lane
5) RNA harvested from cells actively replicating HDV RNA (M; marker).
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HSV-1 infection on various HDV RNA species were first
examined using the H1d9 cell line, which supports the
replication of HDV RNA transcribed from an integrated
trimer HDV cDNA (MacNaughton et al., 1990). In this cell
line, HDAg synthesis was a result of HDV RNA replica-
tion. If the polyadenylated subgenomic mRNA species is
the only template for HDAg synthesis in the HDV-repli-
cating cells, HDAg synthesis would be expected to be
completely inhibited by HSV-1 infection. In contrast, if
another RNA species, such as genome-length anti-
genomic-sense HDV RNA, also serves as a template for
HDAg synthesis, then HDAg synthesis would not be
completely inhibited by HSV-1 infection, provided this
RNA species is resistant to HSV-1-induced degradation.
To examine such a possibility, we first determined
whether the HDV genome-length RNA could be de-
graded by HSV-1 infection.
H1d9 cells were either mock-infected or infected with
HSV-1, and at various time points p.i., total cellular RNA
was harvested and assayed by Northern blotting for
various RNA species. Figure 2 shows that the amounts of
both antigenomic-sense (Fig. 2A, compare lane 1 with
lanes 2–4) and genomic-sense (Fig. 2B, compare lane 1
with lanes 2–4) monomer HDV RNAs were not affected
by HSV-1 infection. This cell line synthesizes a very small
amount of subgenomic HDV RNA species of antigenomic
sense (1.1 kb), which is polyadenylated (Modahl and Lai,
1998). This subgenomic RNA was degraded after HSV-1
infection (Fig. 2A, compare lane 1 with lanes 2–4); thus it
has properties characteristic of an mRNA species, sim-
ilar to the GAPDH mRNA (Fig. 2). As expected, 28S rRNA
was unaffected by HSV-1 infection. These results show
that the genome-length HDV RNA was not degraded
after HSV-1 infection. Similar results were obtained in
COS7 cells transfected with HDV dimer cDNA, which
showed that the genomic- and antigenomic-sense HDV
monomer RNAs were not affected by HSV-1 infection
(data not shown). Therefore the effects of HSV-1 infection
on HDAg synthesis in these systems should be able to
reveal whether HDV-genome-length RNA can serve as a
template for HDAg synthesis.
In the cell culture systems described above, HDV RNA
replication was initiated from DNA-templated transcrip-
tion. Thus there is a possibility that the HDAg mRNA and
HDV monomer RNAs detected were generated by DNA-
dependent RNA transcription. We further examined the
effects of HSV-1 on various HDV RNA species in cells
transfected with HDV RNA. Previously, it has been shown
that HDV RNA transfection led to RNA replication only in
cells constitutively expressing SHDAg (Glenn et al., 1990;
Hwang et al., 1995). Thus TSd3 cells, which synthesize
an mRNA for HDAg from an integrated cDNA (Hwang et
al., 1995), were transfected with an in vitro transcribed
genomic-sense HDV dimer RNA. On day 3 post-transfec-
tion (p.t.), cells were either mock-infected or infected with
HSV-1. Similar to the DNA-transfected cells, monomer
and dimer HDV RNAs of both genomic sense (data not
shown) and antigenomic sense (Fig. 3) were detected,
indicating that the transfected HDV RNA underwent rep-
lication. The accumulation of these RNA species was not
affected by HSV-1 infection (Fig. 3, compare lanes 1–3
with lanes 4–6). In contrast, the endogenous mRNA for
HDAg decreased over time after HSV-1 infection, as did
the mRNA for GAPDH. Similar results were obtained
FIG. 2. Effects of HSV-1 infection on HDV RNA species in H1d9 cells. H1d9 cells were mock-infected (lane 1) or infected with HSV-1 (lanes 2–4),
and various RNA species were assayed by Northern blotting as in Fig. 1. The probes used to detect HDV RNA were genomic-sense (A) and
antigenomic-sense (B) HDV monomer RNA, respectively; these probes detect antigenomic-sense (aG) and genomic-sense (G) HDV RNA, respectively.
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when antigenomic-sense HDV RNA was used for tran-
sient transfection (Fig. 6A); in this case, the genomic-
sense RNA, which represents replicated HDV RNA, was
not affected by HSV-1 infection.
Effect of HSV-1 infection on HDAg synthesis in HDV
RNA-replicating cells
To examine whether the genome-length antigenomic-
sense HDV RNA can serve as a template for HDAg
synthesis, the effect of HSV-1 infection on HDAg synthe-
sis was first examined in H1d9 cells. This experiment
was done in parallel with the experiment presented in
Fig. 2 so the effects of HSV-1 on RNA and protein syn-
thesis could be directly compared. H1d9 cells were ei-
ther mock-infected or infected with HSV-1. At various
times p.i., the cells were labeled with 35S-methionine,
and the radiolabeled proteins were immunoprecipitated
with monoclonal antibodies specific for HDAg. As shown
in Fig. 4, the amount of newly synthesized HDAg de-
creased after HSV-1 infection (compare lane 2 with lanes
3–5), in parallel with the decrease in the subgenomic
mRNA species (Fig. 2A). No residual HDAg synthesis
could be detected by 25 h p.i., even after prolonged
exposure of the film (data not shown). Because genome-
length HDV RNA was not affected by HSV-1 infection, the
complete absence of HDAg synthesis suggests that the
genome-length antigenomic-sense RNA does not con-
tribute in any substantial way to the translation of HDAg,
even though it contains the HDAg ORF. This result was
also confirmed using COS7 cells transfected with HDV
cDNA (Fig. 4, lanes 6–11), in which the synthesis of
HDAg was almost completely inhibited by 9 h p.i. How-
ever, a very faint protein band corresponding to HDAg
was detected at 25 h p.i. This was most likely a contam-
inating HSV protein because it was also detected in the
untransfected COS7 cells infected with HSV-1 (lanes
12–15). Similar results were obtained with TSd3 cells
transfected with HDV dimer RNA (data not shown).
The above conclusion was further tested by examining
the total steady-state HDAg in HDV-replicating cells after
HSV-1 infection. The results showed that almost no
HDAg was detectable by 25 h p.i. (Fig. 5, lane 4), al-
though the rate of decrease for the total HDAg was
slower than that for the newly synthesized HDAg (Fig. 4).
For example, at 9 h p.i. with HSV-1, significant levels of
total HDAg were still detectable (Fig. 5, lane 3), whereas
the level of newly synthesized HDAg was very low at this
time point (Fig. 4, lane 4). These kinetic studies suggest
that the half-life of SHDAg is ,25 h. For comparison,
TFIIB was degraded at a similar rate, whereas actin
appeared to be more stable. The complete disappear-
ance of HDAg while the genomic-length RNA remained
abundant establishes that only the subgenomic anti-
FIG. 3. Effects of HSV-1 infection on HDV RNA species in TSd3 cells
transfected with HDV dimer RNA. TSd3 cells were transfected with HDV
dimer RNA of genomic sense (G). At 63 h post-transfection, cells were
either mock-infected (lanes 1–3) or infected with HSV-1 (lanes 4–6). At
the indicated times p.i., RNA was harvested and assayed by Northern
blotting using genomic-sense HDV monomer RNA as probes.
FIG. 4. Effects of HSV-1 infection on HDAg synthesis. H1d9 cells were either mock-infected (lanes 2) or infected with HSV-1 (lanes 3–5). At various
times p.i., cells were labeled with 35S-methionine and 35S-cysteine for 3 h. Labeled cell lysates were immunoprecipitated with a mixture of monoclonal
antibodies against HDAg. COS7 cells were transfected with a 1.9-kb HDV cDNA of genomic sense (pKS/1.9-G) (lanes 6–11). At 98 h posttransfection,
COS7 cells were mock-infected (lanes 6–8) or infected with HSV-1 (lanes 9–11). At various times p.i., cells were labeled and processed for
immunoprecipitations as above, except that a rabbit anti-HDAg polyclonal antibody was used. Untransfected COS7 cells were mock-infected (lane
12) or infected with HSV-1 (lanes 13–15) as controls. Lane 1 shows in vitro translated SHDAg as a marker (M).
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genomic-sense HDV RNA serves as an mRNA for HDAg
synthesis.
HDV RNA replication is not affected by HSV-1
infection
These results (for both DNA- and RNA-transfected
cells) showed that the level of HDV genome-sized RNA
remained constant despite HSV-1 infection, suggesting
that HSV-1 has very little effect on HDV RNA replication.
However, at the time of HSV-1 infection (between day 3
and day 4 p.t.) in these experiments, the amount of HDV
RNA replication in these transfected cells remained con-
stant even in the absence of HSV-1 infection (Figs. 3 and
6A, compare lanes 1–3 with 4–6). Therefore any potential
effects of HSV-1 infection on HDV RNA replication could
have been masked by the possible effects of HSV-1 on
RNA stability. Thus it was of interest to determine more
directly whether HDV RNA replication itself is affected by
HSV-1 infection, which degrades all cellular and viral
mRNA. For this experiment, HSV-1 infection was per-
formed at days 2–3 p.t., when HDV RNA levels normally
rise very rapidly (Hwang et al., 1995; Kiersten Lo, unpub-
lished results). TSd3 cells were transfected with anti-
genomic-sense HDV RNA as described above. On day
2 p.t., cells were either mock-infected or infected with
HSV-1. Figure 6B demonstrates that the genomic-sense
HDV RNA, which represents replicated HDV RNA, con-
tinued to increase despite the degradation of HDAg
mRNA and consequent inhibition of HDAg synthesis.
Antigenomic-sense monomer HDV RNA accumulated in
parallel with the genomic-sense HDV RNA (data not
shown). Therefore HDV RNA replication is not affected by
HSV-1 infection, suggesting that de novo HDAg synthesis
is not required for HDV RNA replication. Note that the
GAPDH mRNA decreased progressively after HSV-1 in-
FIG. 5. The effect of HSV-1 infection on steady-state levels of HDAg.
H1d9 cells were mock-infected (lane 1) or infected with HSV-1 (lanes
2–4). At the indicated times p.i., cells were harvested for Western blot
analysis using an HDAg-specific polyclonal antibody or TFIIB or actin
polyclonal antibodies.
FIG. 6. The effect of HSV-1 infection on HDV RNA replication. TSd3 cells were transfected with HDV dimer RNA of antigenomic sense. (A) At 63 h
post-transfection (p.t.), cells were either mock-infected (lanes 1–3) or infected with HSV-1 (lanes 4–6). (B) At 52 h p.t., cells were infected with HSV-1.
At the indicated times p.i., RNA was harvested and assayed by Northern blotting, using antigenomic-sense or genomic-sense monomer HDV RNA
as probes to detect replication or HDAg mRNA levels, respectively.
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fection as expected and was almost completely unde-
tectable by 25 h p.i., suggesting that de novo host protein
synthesis also is not required for HDV RNA replication.
Genome-length HDV RNA is not associated with
polysomes
As an alternative approach to identification of the pos-
sible HDV RNA species used for HDAg synthesis, the
association of the various HDV RNA species with poly-
somes was examined. H1d9 cells were lysed by treat-
ment with 0.5% Triton X-100 and fractionated by differen-
tial centrifugation on sucrose gradients. Initial experi-
ments demonstrated that all of the HDV subgenomic
mRNA species were detected in the postmitochondrial
fraction of the cytoplasmic lysate (data not shown). The
postmitochondrial supernatants were fractionated on
15–35% sucrose gradients, and the UV absorbance pro-
file was used to determine polysomal distribution (Fig.
7A). The identity of polysomes was further established by
the finding that the polysomal peak disappeared after
puromycin treatment, which inhibits protein synthesis
and disrupts polysomes; there was a corresponding in-
crease in the monosomal (80S) peak after puromycin
treatment (Fig. 7B). As expected, GAPDH mRNA was
associated mainly with polysomes (Fig. 8A, fraction 9);
after puromycin treatment, the GAPDH mRNA peak
shifted to fraction 4 (Fig. 8B), corresponding to the mono-
somal fraction. In contrast, the genome-length antige-
nomic-sense HDV RNA was mainly in very light fractions
(smaller than the monosomal fraction), and its distribu-
tion did not change appreciably after puromycin treat-
ment, indicating that most of the HDV genome-length
RNA is not associated with polysomes and is not used as
a template for protein synthesis. Although a trace
amount of the antigenomic-sense genome-sized HDV
RNA could be detected in the heavier fractions, it was not
significantly altered by puromycin treatment. Further-
more, the pattern of distribution of the antigenomic-
sense monomer RNA, in both the presence and absence
of puromycin, was similar to that of the genomic-sense
monomer RNA (data not shown), which is unlikely to
serve as an mRNA, suggesting that these RNAs were not
associated with polysomes. The subgenomic HDAg
mRNA was difficult to detect under these conditions;
however, after puromycin treatment, its amount in-
creased, probably as a result of stabilization of the mRNA
by inhibitors of protein synthesis (Ross, 1995), and was
localized to fractions 4 and 5, corresponding to the
monosomal fraction, similar to the distribution of the
cellular mRNA (GAPDH mRNA) (Fig. 8B). The 28S rRNA
FIG. 7. Polysome profiles from H1d9 cell lysates in the absence (A) or presence (B) of puromycin. Puromycin treatment involved adding puromycin
to a final concentration of 200 mg/ml for 2 h before lysing the cells. Polysomes were separated by sucrose gradient sedimentation. Relative positions
of 80S ribosomes and polysomes are indicated. Fraction 1 represents the top of the gradient.
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was broadly distributed in the polysomal preparation.
After puromycin treatment, the majority of the 28S rRNA
was localized to the monosomal fractions.
HDAg is not translated from the genome-length
antigenomic-sense RNA in an IRES-dependent
manner
The genome-length antigenomic-sense HDV RNA ex-
ists as either a circular or linear RNA. The latter molecule
is expected to contain the HDAg ORF at the 39-end of the
RNA and thus have a long 59-untranslated region (UTR)
because the autocleavage site is located just down-
stream of the HDAg ORF (Lai, 1995), whereas the circular
RNA does not have a 59-end. Therefore for HDAg to be
translated from either linear or circular genome-length
antigenomic-sense HDV RNA, translation would have to
be initiated internally, in a cap-independent manner. To
further determine the potential of the genome-length
antigenomic-sense HDV RNA to serve as an mRNA for
HDAg synthesis, we attempted to translate HDAg in vitro
from the genome-length antigenomic-sense HDV RNA
under conditions that favor internal initiation of transla-
tion.
The various constructs used for in vitro transcription-
translation are shown in Fig. 9A. pX9 contains an SHDAg
ORF without the additional 59-UTR. S18 contains the
genome-length antigenomic-sense HDV RNA, in which
the HDAg ORF is at the 39-end of the RNA; this RNA thus
mimics the expected linear HDV RNA in the infected
cells and contains a long 59-UTR. The pCAT-5CL-X con-
struct, which contains the 59-UTR of hepatitis C virus
(HCV) as an internal initiation sequence inserted be-
tween two cistrons, was included as a control. In this
RNA, the chloramphenicol acetyl transferase (CAT) gene
is translated in the 59-end scanning manner, whereas the
core-luciferase (LUC) fused gene is translated in an
IRES-dependent manner (Ito et al., 1998; Tsukiyama-Ko-
hara et al., 1992). Figure 9B shows that when in vitro
translation was carried out at the physiological concen-
tration of KCl (120 mM), which favors IRES-dependent
translation, the core-LUC protein was efficiently trans-
lated from CAT-5CL-X RNA (lane 6). In contrast, HDAg
was not translated from either pX9 (lane 4) or S18 (lane
FIG. 8. Northern analysis of RNA from H1d9 cell lysates untreated (A)
or treated with puromycin (B). The probes used were genomic-sense
HDV monomer RNA, GAPDH, and 28S rRNAs. Lane numbers corre-
spond to fraction numbers as shown in Fig. 7.
FIG. 9. In vitro translation of HDAg. (A) Schematic of plasmids used for in vitro transcription. Arrows indicate the initiation codon (ATG). ORFs are
depicted as boxes, whereas the untranslated sequences are represented by a single horizontal line. (B) In vitro translation products of RNAs in the
presence of 50 mM KCl (lanes 1–3) or 120 mM KCl (lanes 4–6). Arrows indicate the HCV core-LUC fusion protein (top), CAT protein (middle), and HDAg
protein (bottom).
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5). Furthermore, at the low KCl concentration (50 mM),
which allowed efficient translation of 59-end-dependent
translation, as demonstrated by the translation of SHDAg
from pX9 (lane 1) and CAT protein from CAT-5CL-X (lane
3), HDAg was not translated from the S18 RNA (lane 2).
These results indicate that the HDAg ORF cannot be
translated from the HDV RNA by either an internal initi-
ation mechanism or a 59-end scanning mechanism.
Therefore the genome-length antigenomic-sense HDV
RNA is not likely to serve directly as the mRNA template
for HDAg.
DISCUSSION
Although the 0.8-kb subgenomic antigenomic-sense
mRNA has been suggested to be the mRNA for HDAg
synthesis (Hsieh et al., 1990), the fact that this RNA
species is often undetectable in most of the reported
culture systems has raised the possibility that other
RNAs, such as the circular genome-length RNA, may
serve as an alternative mRNA for HDAg synthesis. The
results presented here suggest that this is not likely. This
conclusion was supported by three pieces of evidence.
First, the HDAg synthesis was inhibited completely by
HSV-1 infection, which degrades the conventional mR-
NAs. Under such conditions, the genome-length RNA
remains intact. Second, the genome-length HDV RNA
was not associated with polysomes. Third, the genome-
length HDV RNA does not allow internal initiation of
translation, thus ruling out the possibility of linear or
circular genome-length RNA serving as an mRNA. There-
fore HDAg is most likely translated exclusively from the
0.8-kb mRNA, although the existence of other minor
species of unconventional mRNA cannot be completely
ruled out. Even if such an RNA exists, it will not account
for a significant amount of HDAg synthesis in HDV-
replicating cells. Thus the question of why the amount of
the subgenomic mRNA is so low despite the synthesis of
the large amount of HDAg remains unanswered.
Recently, using a cDNA-free HDV RNA-transfection
system, Modahl and Lai (1998) found that the HDAg
mRNA is present in abundance during HDV replication.
Thus the paucity of subgenomic mRNA in most HDV-
replicating cells may be an artifact of cDNA transfection
or a result of modulation by other host factors. Therefore
the amount of the HDV subgenomic mRNA does not
correlate with the ability of HDV RNA to replicate. De-
spite the small amounts of the HDAg mRNA in most cell
lines, our results showed that other HDV RNA species,
such as the genome-sized RNA, which is the predomi-
nant HDV RNA species, are not used for the translation
of HDAg. Although we did not examine directly the ca-
pacity of the circular RNA to translate HDAg, we showed
that the genome-length antigenomic-sense HDV RNA
cannot be initiated internally (Fig. 9). It is unlikely that the
circular genome-size HDV RNA, which would require
internal initiation because circular RNAs do not have
ends, can be used for translation. These combined re-
sults strongly suggest that the 0.8-kb subgenomic mRNA
species is the only RNA used for HDAg synthesis, de-
spite its small amount in most of the HDV-replicating
cells.
In this study, we took advantage of the ability of HSV-1
to degrade mRNA. This ability is mediated by the vhs
protein of the virus. Thus, vhs mutant viruses are defec-
tive in host shutoff and encode viral mRNAs with dramat-
ically longer half-lives than those of the wild-type virus
(Oroskar and Read, 1987, 1989; Read and Frenkel, 1983;
Strom and Frenkel, 1987). The mechanism of vhs-in-
duced degradation of mRNAs is still poorly understood;
vhs-mediated degradation is specific for mRNAs and
does not affect rRNA or tRNA. Our study further shows
that it does not degrade circular or linear genome-length
HDV RNA and that HDV RNA replication is not inhibited.
Therefore HDV RNA replication intermediates likely have
a structure different from that of mRNAs. Unfortunately,
the structural requirement for vhs-induced mRNA degra-
dation is still not clear. There are in vivo and in vitro data
suggesting that vhs-induced degradation of an mRNA
initiates via endonucleolytic cleavage of the mRNA
downstream from the cap, followed by degradation of the
uncapped RNA sequence (Read, 1997). There also is
evidence suggesting that vhs-induced degradation in
vitro is cap independent (Zelus et al., 1996). In addition,
the requirement of a poly(A)1 tail in the mRNA for vhs-
induced degradation is controversial (Read, 1997; Zelus
et al., 1996). Thus we cannot infer from our study the
structure of the HDV RNA replication intermediates. Nev-
ertheless, our finding that HDV RNA replication was not
inhibited by HSV-1 infection suggests that the structures
of HDV RNA replication intermediates are dissimilar to
those of mRNAs, which is consistent with the proposal
that transcription of the subgenomic HDV mRNA may be
independent of HDV genomic RNA replication (Modahl
and Lai, 1998).
The polysomal experiments in H1d9 cells showed that
the HDV antigenomic-sense RNA is not associated with
polysomes. The subgenomic mRNA was difficult to de-
tect because of its small amount; nevertheless, it be-
came detectable after puromycin treatment and was as-
sociated with the monosomal fraction. These findings
suggest that the 0.8-kb subgenomic mRNA is the only
functional mRNA. Although we cannot rule out com-
pletely the possibility that some other unconventional
HDV RNA species may serve as an alternative mRNA for
HDAg synthesis, such RNA species are not likely to
contribute significantly to HDAg synthesis in HDV-in-
fected cells because HDAg synthesis was completely
inhibited by HSV-1 infection.
Our studies also showed that HDV genomic RNA con-
tinued to be synthesized during HSV-1 infection, even
though HDAg is no longer synthesized after 9 h p.i. (Fig.
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4) and very little HDAg is available at 25 h p.i. (Fig. 5).
These results indicate that HDV RNA replication is not
linked to de novo HDAg synthesis. It is likely that only
very small amounts, if any, of HDAg are required for
ongoing HDV RNA replication. The precise functional
roles of HDAg in HDV RNA replication will require further
studies.
MATERIALS AND METHODS
Cells
TSd3 cells, derived from a temperature-sensitive hamster
kidney cell line, ts13 (Wang and Tjian, 1994), contain an
integrated copy of the SHDAg ORF and constitutively ex-
press HDAg (Hwang et al., 1995). TSd3 cells were grown at
33.5°C and 5% CO2 in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum (FCS), 800
mg/ml G418, and penicillin–streptomycin. H1d9 cells, de-
rived from the human hepatoma cell line PLC/PRF/5,
contain an integrated copy of HDV cDNA trimer of anti-
genomic sense under the control of the Rous sarcoma
virus LTR promoter and constitutively express HDV RNA
and HDAg (MacNaughton et al., 1990). H1d9 cells were
grown at 37°C in DMEM supplemented with 5–10% FCS
and penicillin–streptomycin. Vero cells (African green
monkey kidney cells; American Type Culture Collection
CRL-1586) and COS7 cells (African green monkey kidney
cells) were grown at 37°C in DMEM supplemented with
5–10% FCS and penicillin–streptomycin.
Virus
The KOS strain of HSV-1 was a kind gift from G. S.
Read of The University of Missouri-Kansas City. To pre-
pare virus stocks, HSV-infected Vero cells were grown in
MEM (minimum essential media) plus 1% FCS with peni-
cillin–streptomycin. Medium was harvested at 2–3 days
p.i., when the cytopathic effect (CPE) was evident; virions
were purified by brief sonication followed by centrifuga-
tion at 500 g for 15 h at 4°C, and then aliquoted for
storage at 280°C. Virus titer was determined by plaque
assay on Vero cells.
Plasmids
pRC/D-G and pRC/D-aG contain an HDV cDNA dimer,
cloned into the HindIII site, downstream of both the CMV
and T7 promoters in the vector pRc/CMV (InVitrogen), so
that they transcribe 3.4-kb genomic- and antigenomic-
sense HDV RNAs, respectively (Polo et al., 1995b). Plas-
mid S18 contains an SalI–SalI monomer fragment of HDV
cDNA cloned downstream of the T7 promoter in the
antigenomic sense, so the ORF for HDAg (nt 1601–965) is
located at the 39 end of the HDV DNA. Plasmid S29
contains the SalI–SalI HDV cDNA cloned downstream of
the T7 promoter in the genomic sense. S18 and S29
contain a HindIII site downstream of the HDV sequences
(Xia and Lai, 1992). pX9 contains a BamHI–PstI fragment
encoding SHDAg downsream of the T7 promoter in a pT7
vector (Chang et al., 1988). pKS/HDV1.9 (Jeng et al., 1996)
contains a monomer plus ;200 additional nucleotides
(1.9 kb) of HDV cDNA cloned downstream of both the
CMV promoter and the T7 promoters in the genomic-
sense orientation. pI-19 contains a 4.8-kb EcoRI–SalI
cDNA fragment of mouse 28S rRNA (Tiemeier et al.,
1977) in the vector pBK. pSPGAP contains a 1.2-kb cDNA
fragment of GAPDH RNA (Tso et al., 1985) cloned into
pSP72 (Promega), so digestion with PstI and XbaI yields
a 780-bp fragment containing 59 noncoding sequences
plus the coding sequence for the first 250 amino acids of
GAPDH. Plasmid pCAT-5CL-X contains a T7 promoter,
the CAT gene, and the 59-UTR and the entire core pro-
tein-encoding region of HCV genotype 1b strain, the
luciferase gene, and the 39-end 98 nt (X region) of HCV,
fused in frame as described (Ito et al., 1998).
DNA and RNA transfection
For both DNA and RNA transfections, N-[1-(2,3-dio-
leoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate
(DOTAP; Boehringer Mannheim) was used according to
the manufacturer’s instruction.
HSV infection procedure and mRNA degradation
assay
Cells (2–3 3 106) in 6-cm plates were mock-infected or
infected with HSV-1, and total cellular RNA was har-
vested at various times p.i. according to the guanidinium
thiocyanate method (Chomczynski and Sacchi, 1987) and
analyzed by Northern blotting.
Northern blot analysis
The RNA was denatured with 1 M glyoxal and sepa-
rated by electrophoresis on a 1.1% agarose gel as de-
scribed previously (Sambrook et al., 1989). RNA was then
transferred onto a positively charged nylon membrane
(Hybond-N1; Amersham) in 203 standard saline citrate
(3 M NaCl, 0.3 M Na3 citratez2H20, pH 7.0) by capillary
blotting, covalently linked to the membrane by baking at
80°C for 2 h, and then probed with the 32P-labeled
probes described below.
Strand-specific riboprobes for detecting genomic- and
antigenomic-sense HDV RNA were transcribed with T7
RNA polymerase from HindIII-linearized plasmids S18
and S29, respectively (Hwang and Lai, 1994). DNA
probes specific for the 28S ribosomal RNA and GAPDH
were prepared from plasmid pI-19 and the PstI–XbaI
fragment of pSPGAP, respectively, by using a Random
Primed DNA Labeling Kit (Boehringer-Mannheim).
Filters were first probed for GAPDH RNA and 28S
rRNA, stripped, and then reprobed for HDV RNA. Hybrid-
ization solutions and conditions for HDV riboprobes were
as described previously (Hwang and Lai, 1994). The
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conditions used for GAPDH and 28S rRNA probes were
similar, except that membranes were hybridized at 42°C
and washed at 55°C.
Cell labeling and immunoprecipitation
At 4 h before the desired harvest time points, cells
were washed once with serum-free DMEM and then
incubated in methionine- and cysteine-free DMEM (ICN)
containing 1% FCS for 1 h. Then, the medium was re-
placed with 35S-methionine- and -cysteine (100 mCi/ml;
.1000 Ci/mmol; NEN)-containing medium supple-
mented with 1% FCS and incubated for an additional 3 h.
The labeling medium was removed, and cells were har-
vested essentially as described previously (Hwang and
Lai, 1994). Briefly, cells from 6-cm plates were washed in
PBS and incubated in 800 ml of radioimmunoprecipita-
tion assay (RIPA) buffer [150 mM NaCl, 1% Nonidet-P40,
1% deoxycholate, 0.1% SDS, 50 mM Tris–HCl (pH 8), 0.1
mM Pefabloc; Boehringer-Mannheim] on ice for 20 min.
Lysed cells were scraped into Eppendorf tubes and
further incubated on ice for 10 min with occasional vor-
texing. Cell lysates were further disrupted by passage
through a 25-guage syringe needle 10 times and cleared
of cell debris by two consecutive centrifugations at
16,000 g for 10 min at 4°C.
For immunoprecipitations using H1d9 cells, one half of
the 35S-methionine- and -cysteine-labeled cell lysate per
plate was diluted to 0.5 ml with a gelatin-containing
NET-gel buffer (Sambrook et al., 1989) and incubated
with a mixture of two HDAg-specific monoclonal antibod-
ies (3G3 and 9E4) (Hwang and Lai, 1993) at 4°C for 1 h
with constant rocking. Protein A–Sepharose (Pharmacia)
was then added and samples rocked for an additional
hour at 4°C. The Sepharose beads were washed four
times with RIPA buffer as described (Sambrook et al.,
1989), and the immunoprecipitated proteins were eluted
from the beads by boiling in Laemmli’s sample buffer
(Laemmli, 1970) and separated by SDS–PAGE on a 15%
polyacrylamide gel.
For experiments using COS7 cells, the immunoprecipi-
tations were performed using a rabbit anti-HDAg poly-
clonal antibody as described previously (Hwang and Lai,
1993).
Western blot analysis
Cells were washed twice in PBS and lysed in Lae-
mmli’s sample buffer by boiling for 10 min. Chromosomal
DNA was sheared by passage through a 21-gauge nee-
dle, and cell debris was removed by microcentrifugation
for 10 min. Aliquots of supernatant were electrophoresed
on 15% polyacrylamide gels, and proteins were trans-
ferred to Protran transfer membranes (Schleicher &
Schuell) as described previously (Sambrook et al., 1989).
After transfer, immunoblotting was carried out using rab-
bit anti-HDAg polyclonal antibody and a chemilumines-
cence detection kit (Boehringer-Mannheim). Control an-
tibodies used were goat polyclonal anti-actin (Santa Cruz
Biotechnology) and rabbit polyclonal anti-TFIIB (Santa
Cruz Biotechnology).
Polysome analysis
A modification of a protocol described by Duncan and
Hershey (1984) was used to isolate polysomes. Approx-
imately 7 3 106 monolayer cells were washed three
times with PBS (4°C), pelleted by centrifugation at 500 g,
and then resuspended in 1 ml of lysis buffer P (125 mM
KCl, 37.5 mM MgCl2, 25 mM EGTA, 10 mM HEPES, pH
6.8, 1 mM dithiothreitol, 200 mM sucrose, 0.5% Triton
X-100) on ice. The cell lysate was centrifuged at 4°C for
1 min at 16,000 g, and the polysome-containing super-
natant was layered over a linear 15–35% sucrose gradi-
ent made in buffer P that lacked sucrose and detergents.
The gradients were centrifuged at 36,000 rpm for 2 h at
4°C (SW41 rotor, Beckman Instruments) and were
scanned at 254 nm. Duplicate gradients prepared for
RNA analysis were not scanned; after ultracentrifugation,
1-ml fractions were collected, and an equal volume of a
denaturing urea-sodium dodecyl sulfate buffer [7 M urea,
350 mM NaCl, 10 mM Tris–HCl, pH 7.6, 10 mM EDTA, 1%
SDS] was added to each fraction (Smale and Tjian, 1985).
The fractions were then extracted with phenol–chloro-
form (1:1), and the RNA in the fractions was recovered by
ethanol precipitation. Total RNA from each fraction was
analyzed by Northern blot analysis as described above.
When indicated, cells were treated with 200 mg/ml pu-
romycin for 2 h before lysing the cells.
In vitro RNA transcription and translation
Plasmids were linearized by digestion with HindIII (for
pX9 and S18) or BamHI (for pCAT-5CL-X). RNA was tran-
scribed by T7 RNA polymerase as described in the Pro-
mega protocol. After transcription, the DNA templates
were digested by the addition of 1 U of DNase (Pro-
mega). The reaction mixture was then extracted with
phenol–chloroform and precipitated with ethanol. The
concentration of RNA was measured by spectrophotom-
etry and confirmed by agarose gel analysis.
In vitro translation was carried out using micrococcal
nuclease-treated rabbit reticulocyte lysates (Flexi; Pro-
mega). Each translation reaction mixture contained 2 mg
of RNA, 10 ml of lysate, 0.5 U of RNase inhibitor (RNAsin;
Promega), 2 mM dithiothreitol, 20 mM amino acid mixture
minus methionine, various concentrations of KCl (50 mM
or 120 mM), and 1 ml of [35S]methionine (10 mCi/ml;
NEN). The final reaction volume was 25 ml, and reaction
mixtures were incubated for 90 min at 30°C. Reactions
were terminated by the addition of stop buffer (50 mg/ml
RNase A, 10 mM EDTA, pH 7.5), and aliquots of the
translation products were separated by SDS–PAGE on a
10% polyacrylamide gel.
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